Home > Insider Trading > Filing (0001126234-15-000060)

Filing Details

Accession Number:: 0001126234-15-000060
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2015-03-19 17:10:18
Reporting Period:: 2015-01-08

Filing Date:: 2015-03-19
Accepted Time:: 2015-03-19 17:10:18
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1126234	Newlink Genetics Corp	(NLNK)	Pharmaceutical Preparations (2834)	421491350

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1512132	Iii Ernest Talarico	C/O Newlink Genetics Corporation 2503 South Loop Dr., Suite 5100 Ames IA 50010		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2015-01-08	1,438	$0.00	26,196	No	4	G	Direct
Common Stock	Acquisiton	2015-01-08	719	$0.00	1,564	No	4	G	Indirect	By son's trust
Common Stock	Acquisiton	2015-01-08	719	$0.00	1,564	No	4	G	Indirect	By daughter's trust
Common Stock	Acquisiton	2015-03-17	19,532	$2.10	45,728	No	4	M	Direct
Common Stock	Disposition	2015-03-17	19,532	$52.89	26,196	No	4	S	Direct
Common Stock	Acquisiton	2015-03-18	1,000	$2.10	27,196	No	4	M	Direct
Common Stock	Disposition	2015-03-18	1,000	$53.75	26,196	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	G	Direct
No	4	G	Indirect	By son's trust
No	4	G	Indirect	By daughter's trust
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to Buy)	Disposition	2015-03-17	19,532	$0.00	19,532	$2.10
Common Stock	Stock Option (Right to Buy)	Disposition	2015-03-18	1,000	$0.00	1,000	$2.10

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
4,093	2004-01-30	2018-07-15	No	4	M	Direct
3,093	2004-01-30	2018-07-15	No	4	M	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	1,737	Indirect	-
Common Stock	977	Indirect	-

Footnotes

Includes 2,944 restricted stock units ("RSUs") previously reported as holdings of the Reporting Person granted under the Issuer's 2010 Non-Employee Directors' Stock Award Plan (the "Plan"). One hundred percent (100%) of the RSUs will vest on the earlier of (i) the first anniversary of the date of grant and (ii) the date of the first Annual Meeting following the date of grant, in each case subject to the Reporting Person's continuous service as of such date.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $52.80 to $53.00, inclusive. The reporting person undertakes to provide to the issuer, any security holder of issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in this footnote to this Form 4.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $53.75 to $53.77, inclusive. The reporting person undertakes to provide to the issuer, any security holder of issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in this footnote to this Form 4.
These shares are held by the spouse of the Reporting Person in a Roth IRA account.
These shares are held by the Reporting Person in a Roth IRA account.
Grant to the Reporting Person of a stock option under the Issuer's 2009 Equity Incentive Plan (the "Plan"). The option is fully vested.